Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Procyanidin Potential treatment - theoretical effect Natural product Antiviral Sep/22/2020 Oct/15/2020 0
25-hydroxycholesterol  Potential treatment - pre-clinical evidence Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Leucopelargonidin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Myricetin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Luteolin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
1-(3-Methoxy-4-hydroxyphenyl)-5-hydroxy-7-(3,4-dihydroxyphenyl)-3-heptanone Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Aromadendrin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Tricetin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Sep/17/2020 Oct/16/2020 0